Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users.
To examine sex-specific risk factors for human immunodeficiency virus (HIV) type 1 seroconversion among intravenous drug users, the authors conducted a nested case-control study in Baltimore, Maryland, from 1988 to 1992 comparing 146 seroconverters and 539 HIV seronegative controls.
Controls were matched on sex, race, date of study entry, and duration of follow-up.
Risk factor data were obtained from interviews conducted at the first seroconversion visit for the case and the closest visit for the corresponding seronegative control.
Since test results were not available until several weeks after interview, both interviewers and participants were unaware of seroconversion status at the time of interview.
Mots-clés Pascal : Immunodéficit acquis syndrome, Virose, Infection, Toxicomanie, Sexe, Immunopathologie, Hémopathie, Voie intraveineuse, Homme, Epidémiologie, Etude cohorte, Facteur risque, Virus HIV1, Virus immunodéficience humaine, Lentivirinae, Retroviridae, Virus, Incidence, Maryland, Etats Unis, Amérique du Nord, Amérique, Etude cas témoin
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Drug addiction, Sex, Immunopathology, Hemopathy, Intravenous administration, Human, Epidemiology, Cohort study, Risk factor, HIV-1 virus, Human immunodeficiency virus, Lentivirinae, Retroviridae, Virus, Incidence, Maryland, United States, North America, America, Case control study
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0517058
Code Inist : 002B06D01. Création : 199406.